|
gptkbp:instance_of
|
gptkb:pharmaceuticals
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Zymeworks
gptkb:Nant_Kwest,_Inc.
gptkb:Alder_Bio_Pharmaceuticals,_Inc.
gptkb:Archer_DX
gptkb:Archer_DX,_Inc.
gptkb:Envoy_Therapeutics,_Inc.
gptkb:Kite_Pharma
gptkb:Ligo_Cyte_Pharmaceuticals,_Inc.
gptkb:Medi_Gene_AG
gptkb:Pioneer_Pharmaceuticals
gptkb:Pioneer_Pharmaceuticals,_Inc.
gptkb:Tetra_Logic_Pharmaceuticals
gptkb:Tetra_Logic_Pharmaceuticals,_Inc.
gptkb:Ti_Genix
gptkb:Ti_Genix_NV
gptkb:Shire_(2019)
gptkb:Apexigen
gptkb:Tigenix
gptkb:Envoy_Therapeutics
gptkb:Shire_plc
gptkb:Apexigen,_Inc.
gptkb:Zymeworks_Inc.
gptkb:Hikma_Pharmaceuticals
gptkb:Kite_Pharma,_Inc.
gptkb:Alder_Bio_Pharmaceuticals
gptkb:Nant_Kwest
Acquired Shire in 2019
Hikma Pharmaceuticals PLC.
Ligo Cyte Pharmaceuticals
Medi Gene AG.
Shire plc.
Ti Genix NV.
|
|
gptkbp:allies
|
gptkb:Astra_Zeneca
gptkb:Sanofi
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Amgen
gptkb:Eisai
gptkb:Hikma_Pharmaceuticals
gptkb:Shire_Pharmaceuticals
gptkb:Mitsubishi_Tanabe_Pharma
gptkb:Novartis
|
|
gptkbp:awards
|
Various industry awards
|
|
gptkbp:ceo
|
gptkb:Christophe_Weber
|
|
gptkbp:clinical_trial
|
Conducts extensive clinical research
Conducts worldwide
|
|
gptkbp:community_engagement
|
Supports local communities
|
|
gptkbp:community_health
|
Engages in global health initiatives
|
|
gptkbp:cultural_diversity
|
Promotes workplace diversity
|
|
gptkbp:employees
|
Over 50,000
50,000+
|
|
gptkbp:financial_performance
|
Consistent revenue growth
|
|
gptkbp:financial_support
|
Offers patient assistance programs
|
|
gptkbp:focus
|
gptkb:Research_and_development
gptkb:Oncology
Gastroenterology
Neuroscience
Vaccines
Biopharmaceuticals
Rare diseases
Research and development of pharmaceuticals
|
|
gptkbp:focus_area
|
gptkb:Oncology
Gastroenterology
Neuroscience
Vaccines
Rare diseases
|
|
gptkbp:founded
|
1781
|
|
gptkbp:founder
|
gptkb:Chobei_Takeda_I
|
|
gptkbp:governance
|
gptkb:Board_of_Directors
|
|
gptkbp:headquarters
|
gptkb:Osaka,_Japan
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Takeda Pharmaceutical Company
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:innovation
|
Focus on innovative therapies
|
|
gptkbp:investment
|
Invests in new technologies
|
|
gptkbp:leadership
|
Diverse leadership team
|
|
gptkbp:market_position
|
Global presence in over 80 countries
|
|
gptkbp:mission
|
Better health for people worldwide
|
|
gptkbp:partnership
|
gptkb:Microsoft
gptkb:Amgen
gptkb:Novartis
|
|
gptkbp:partnerships
|
Various global health organizations
Collaborates with academic institutions
Works with biotech companies
|
|
gptkbp:philanthropy
|
Contributes to health initiatives
|
|
gptkbp:products
|
Vaccines
Oncology drugs
Gastroenterology drugs
Rare disease treatments
|
|
gptkbp:regulatory_compliance
|
Adheres to global regulations
|
|
gptkbp:research_and_development
|
Global R& D centers
|
|
gptkbp:research_areas
|
gptkb:Oncology
Gastroenterology
Rare diseases
|
|
gptkbp:revenue
|
$30 billion (2022)
|
|
gptkbp:stock_exchange
|
gptkb:Tokyo_Stock_Exchange
|
|
gptkbp:stock_symbol
|
4502
4502 (TSE)
TAK (NYSE)
4502. T
|
|
gptkbp:strategic_goals
|
Enhance operational efficiency
Expand global footprint
Drive innovation in drug development
Commit to sustainability practices
Focus on patient needs
Foster collaboration with stakeholders
Strengthen pipeline of new therapies
|
|
gptkbp:subsidiaries
|
gptkb:Shire_plc
|
|
gptkbp:subsidiary
|
gptkb:Takeda_Pharmaceuticals_International_AG
gptkb:Takeda_Pharmaceuticals_U._S._A.,_Inc.
gptkb:Takeda_Global_Research_&_Development_Center,_Inc.
gptkb:Takeda_Pharmaceuticals_USA,_Inc.
|
|
gptkbp:sustainability_initiatives
|
Social responsibility
Environmental responsibility
Governance practices
|
|
gptkbp:traded_on
|
gptkb:Tokyo_Stock_Exchange
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:values
|
gptkb:Perseverance
Integrity
Teamwork
Fairness
Honesty
|
|
gptkbp:vision
|
Leading the way in patient-centric healthcare.
|
|
gptkbp:website
|
www.takeda.com
takeda.com
|
|
gptkbp:bfsParent
|
gptkb:Astra_Zeneca
gptkb:Pfizer
gptkb:Biogen
gptkb:Cure_Vac
|
|
gptkbp:bfsLayer
|
4
|